ACUTAAS

Acutaas Chemicals Share Price

 

 

Acutaas Chemicals live price: ₹2362.2. It opened at ₹2,350 vs previous close ₹2,322; intraday high/low: ₹2,394/₹2,313. The 50 & 200 DMA stand at ₹2,159.83/₹1,741.00.

Acutaas Chemicals Performance

  • Today's Low
  • ₹2,313
  • Today's High
  • ₹2,394
  • 52 Week Low
  • ₹1,041
  • 52 Week High
  • ₹2,635
  • Open Price₹2,350
  • Previous Close₹2,322
  • Volume296,389
  • 50 DMA₹2,159.83
  • 100 DMA₹1,982.29
  • 200 DMA₹1,741.00

Investment Returns

  • Over 1 Month + 9.64%
  • Over 3 Month + 40.17%
  • Over 6 Month + 66.19%
  • Over 1 Year + 121.52%

Smart Investing Starts Here Start SIP with Acutaas Chemicals for Steady Growth!

Invest Now

Acutaas Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 67.4
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 19,340
  • P/B Ratio
  • 12.7
  • Average True Range
  • 131.83
  • EPS
  • 35.05
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 63.26
  • RSI
  • 54.97
  • MFI
  • 63.9

Acutaas Chemicals Financials

Acutaas Chemicals Technicals

EMA & SMA

Current Price
₹2,362.20
+ 40.1 (1.73%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,291.38
  • 50 Day
  • ₹2,159.83
  • 100 Day
  • ₹1,982.29
  • 200 Day
  • ₹1,741.00

Resistance and Support

2356.43 Pivot Speed
  • R3 2,480.67
  • R2 2,437.33
  • R1 2,399.77
  • S1 2,318.87
  • S2 2,275.53
  • S3 2,237.97

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ami Organics Ltd. is a leading manufacturer of specialty chemicals and pharmaceutical intermediates, serving global pharmaceutical companies. With advanced R&D and manufacturing facilities, it focuses on developing high-quality, innovative solutions for diverse therapeutic areas.

Acutaas Chemicals Ltd has an operating revenue of Rs. 1,215.10 Cr. on a trailing 12-month basis. An annual revenue growth of 41% is outstanding, Pre-tax margin of 21% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 41% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 96 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 83 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of A is the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Acutaas Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-28 Quarterly Results
2025-10-17 Quarterly Results
2025-07-30 Quarterly Results
2025-05-02 Audited Results & Final Dividend
2025-02-21 Stock Split
Date Purpose Remarks
2025-09-18 FINAL Rs.1.50 per share(30%)Final Dividend
2024-09-13 FINAL Rs.3.00 per share(30%)Final Dividend
2023-09-18 FINAL Rs.3.00 per share(30%)Final Dividend
2022-08-01 FINAL Rs.3.00 per share(30%)Final Dividend
View Acutaas Chemicals Dividend History Arrow
Date Purpose Remarks
2025-04-25 Split Rs.0.00 split from Rs. 10/- to Rs. 5/-/

Acutaas Chemicals F&O

Acutaas Chemicals Shareholding Pattern

32.66%
15.11%
4.15%
16.67%
23.53%
7.88%

Acutaas Chemicals FAQs

Acutaas Chemicals share price is ₹2,362 As on 10 April, 2026 | 22:04

The Market Cap of Acutaas Chemicals is ₹19339.6 Cr As on 10 April, 2026 | 22:04

The P/E ratio of Acutaas Chemicals is 67.4 As on 10 April, 2026 | 22:04

The PB ratio of Acutaas Chemicals is 12.7 As on 10 April, 2026 | 22:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23